Literature DB >> 17009926

Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.

John A Dani1, Daniel Bertrand.   

Abstract

Subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) are constructed from numerous subunit combinations that compose channel-receptor complexes with varied functional and pharmacological characteristics. Structural and functional diversity and the broad presynaptic, postsynaptic, and nonsynaptic locations of nAChRs underlie their mainly modulatory roles throughout the mammalian brain. Presynaptic and preterminal nicotinic receptors enhance neurotransmitter release, postsynaptic nAChRs contribute a small minority of fast excitatory transmission, and nonsynaptic nAChRs modulate many neurotransmitter systems by influencing neuronal excitability. Nicotinic receptors have roles in development and synaptic plasticity, and nicotinic mechanisms participate in learning, memory, and attention. Decline, disruption, or alterations of nicotinic cholinergic mechanisms contribute to dysfunctions such as epilepsy, schizophrenia, Parkinson's disease, autism, dementia with Lewy bodies, Alzheimer's disease, and addiction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17009926     DOI: 10.1146/annurev.pharmtox.47.120505.105214

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  456 in total

Review 1.  Is there evidence for potential harm of electronic cigarette use in pregnancy?

Authors:  Melissa A Suter; Joan Mastrobattista; Maike Sachs; Kjersti Aagaard
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-11-04

Review 2.  Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.

Authors:  Asti Jackson; Ben Grobman; Suchitra Krishnan-Sarin
Journal:  Neuropharmacology       Date:  2020-06-24       Impact factor: 5.250

3.  Neurochemistry: Lighting up with azobenzenes.

Authors:  G Andrew Woolley
Journal:  Nat Chem       Date:  2012-01-24       Impact factor: 24.427

4.  Phylogenetic differences in calcium permeability of the auditory hair cell cholinergic nicotinic receptor.

Authors:  Marcela Lipovsek; Gi Jung Im; Lucía F Franchini; Francisco Pisciottano; Eleonora Katz; Paul Albert Fuchs; Ana Belén Elgoyhen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

Review 5.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

6.  Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; David R Lynch
Journal:  Neurobiol Dis       Date:  2013-12-08       Impact factor: 5.996

7.  Modulation of HCN channels in lateral septum by nicotine.

Authors:  Sodikdjon A Kodirov; Michael Wehrmeister; Luis V Colom
Journal:  Neuropharmacology       Date:  2014-02-26       Impact factor: 5.250

8.  Diverse inhibitory actions of quaternary ammonium cholinesterase inhibitors on Torpedo nicotinic ACh receptors transplanted to Xenopus oocytes.

Authors:  Silvia Olivera-Bravo; Isabel Ivorra; Andrés Morales
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

9.  Alkaloids from Microcos paniculata with cytotoxic and nicotinic receptor antagonistic activities.

Authors:  Patrick C Still; Bitna Yi; Tatiana F González-Cestari; Li Pan; Ryan E Pavlovicz; Hee-Byung Chai; Tran Ngoc Ninh; Chenglong Li; Djaja Djendoel Soejarto; Dennis B McKay; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2013-01-17       Impact factor: 4.050

10.  Memory enhancing effects of nicotine, cocaine, and their conditioned stimuli; effects of beta-adrenergic and dopamine D2 receptor antagonists.

Authors:  Michael Wolter; Thomas Lapointe; Brett Melanson; Nana Baidoo; Travis Francis; Boyer D Winters; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2021-06-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.